The American Heart Association and the American Stroke Association issued guidelines Monday that also look at the effects of testosterone and estrogen on the body. Meanwhile, Eli Lilly sues three ...

As with any new drug, parents and doctors may worry that the use of GLP-1 weight-loss meds by children and teens might raise psychiatric risks, including the risk for suicide and suicidal thoughts.

GLP-1 agonist medications have gained significant attention, especially for their role in weight management and type 2 diabetes treatment. While these medications have been around for nearly 20 ...

Medicines affecting the GLP-1 receptor are in vogue for weight loss right now. Zealand Pharma has GLP-1 candidates, but also a compelling alternative approach. BioAge Labs' lead program could ...

As with any new drug, parents and doctors may worry that the use of GLP-1 weight-loss meds by children and teens might raise psychiatric risks, including the risk for suicide and suicidal thoughts.

I know that SSRIs can be a real mixed bag; I'm one of the lucky one-third who has never achieved "remission." Taking an SSRI ...

However, GLP-1-based therapies aren't going to be the only option in the weight loss medicines market forever. Some companies are pursuing other approaches that could be even more effective or ...

Concerns that the new GLP-1 weight-loss meds might raise suicide risks in adolescents may be eased by the results of new research The study of more than 54,000 kids found no rise in risk ...

GLP-1 Weight-Loss Meds Won't Raise Teens' Suicide Risk, May Even Lower It MONDAY, Oct. 14, 2024 (HealthDay News) -- As with any new drug, parents and doctors may worry that the use of GLP-1 weight ...

Concerns that the new GLP-1 weight-loss meds might raise suicide risks in adolescents may be eased by the results of new research The study of more than 54,000 kids found no rise in risk, and a 33% ...